Sana Biotech valued at over $6 bln in market debut
Feb 4 (Reuters) - Shares of gene-regulation startup Sana Biotechnology Inc surged 40% in their U.S. stock market debut on Thursday, giving the...
Feb 4 (Reuters) - Shares of gene-regulation startup Sana Biotechnology Inc surged 40% in their U.S. stock market debut on Thursday, giving the...